News & Resources

SEC Filings

<< Back
Form 8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 04/24/2018
Document Outline
Entire Document (587.6 KB)
Subdocument 1 - 8-K - FORM 8-K
Page 1 - UNITED STATES
Page 2 - Key Employee Incentive Plan
Page 3 - Key Employee Retention Plan
Page 4 - Additional Information regarding the Chapter 11 Case
Page 5 - SIGNATURES
Subdocument 2 - EX-2.1 - EX-2.1
Page 1 - Exhibit 2.1
Page 2 - TABLE OF CONTENTS
Page 3 - N/A
Page 4 - Exhibits
Page 5 - N/A
Page 6 - ASSET PURCHASE AGREEMENT
Page 7 - ARTICLE 1
Page 8 - Assumption Procedures
Page 9 - Chapter 11 Case
Page 10 - Contract
Page 11 - Equity Financing
Page 12 - Governmental Authorization
Page 13 - Knowledge of the Seller
Page 14 - Materials of Environmental Concern
Page 15 - Petition
Page 16 - Schedule
Page 17 - Supplement
Page 18 - ARTICLE 2
Page 19 - Authorizations
Page 20 - Books and Records
Page 21 - Section 2.3
Page 22 - Excluded Liabilities
Page 23 - Excluded Assets
Page 24 - Section
Page 25 - Purchaser
Page 26 - Section
Page 27 - Section 3.2
Page 28 - Section 3.5
Page 29 - Section 3.7
Page 30 - Section
Page 31 - Section 3.10
Page 32 - Section 3.12
Page 33 - Schedule
Page 34 - Section 3.16
Page 35 - Orexigen Ireland Subsidiary Securities
Page 36 - Section 4.4
Page 37 - Section
Page 38 - N/A
Page 39 - Schedule 3.5
Page 40 - Section
Page 41 - Section 5.4
Page 42 - Section 5.5
Page 43 - Section
Page 44 - Outside Date
Page 45 - Section 5.10
Page 46 - Section
Page 47 - Section
Page 48 - Section
Page 49 - pro rata
Page 50 - provided
Page 51 - No Material Adverse Effect
Page 52 - Section
Page 53 - Section 7.3
Page 54 - Section
Page 55 - Section 9.3
Page 56 - Purchaser
Page 57 - Section 10.4
Page 58 - Section 10.8
Page 59 - Section 10.13
Page 60 - provided
Page 61 - N/A
Page 62 - PURCHASER:
Subdocument 3 - EX-10.1 - EX-10.1
Page 1 - Exhibit 10.1
Page 2 - Key Employee Incentive Plan and Key Employee Retention Plan, and (iii)
Page 3 - Employee Compensation Plans
Page 4 - the Declaration of Michael A. Narachi in
Page 5 - BASIS FOR RELIEF
Page 6 - Exhibit A
Page 7 - Table 1
Page 8 - Table 2
Page 9 - The KEIP Design is Consistent with the Bankruptcy Market
Page 10 - N/A
Page 11 - N/A
Page 12 - KERP Participants
Page 13 - N/A
Page 14 - N/A
Page 15 - APPLICABLE AUTHORITY
Page 16 - See Dai-Ichi Kangyo Bank Ltd. v. Montgomery
Page 17 - Official Comm. of Subordinated Bondholders v. Integrated Res., Inc.
Page 18 - See, e.g.
Page 19 - See In re Velo Holdings Inc.
Page 20 - See In re Global Home Prods., LLC
Page 21 - N/A
Page 22 - See In re Dana Corp.
Page 23 - RESERVATION OF RIGHTS
Page 24 - NOTICE
Page 25 - N/A
Page 26 - EXHIBIT A
Page 27 - N/A
Page 28 - N/A
Page 29 - Table 1
Page 30 - N/A
Page 31 - EXHIBIT B
Page 32 - KEY EMPLOYEE RETENTION PLAN TERM SHEET
Page 33 - EXHIBIT C
Page 34 - IN THE UNITED STATES BANKRUPTCY COURT
Page 35 - ORDERED, ADJUDGED AND DECREED that:
Page 36 - N/A
Page 37 - IN THE UNITED STATES BANKRUPTCY COURT
Page 38 - N/A
Page 39 - IN THE UNITED STATES BANKRUPTCY COURT
Page 40 - ORDERED, ADJUDGED AND DECREED that:
Page 41 - N/A
Subdocument 4 - EX-99.1 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - Motion
Page 3 - Exhibit 1
Page 4 - Exhibit 4
Page 5 - IT IS HEREBY ORDERED, ADJUDGED AND DECREED THAT:
Page 6 - Bid Deadline
Page 7 - Baseline Bid
Page 8 - N/A
Page 9 - II. Approval of the Sale and Assignment and Procedures Notices
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Subdocument 5 - EX-99.2 - EX-99.2
Page 1 - Exhibit 99.2
Page 2 - www.kccllc.net/orexigen
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - bsilver@pwpartners.com